RENHENG Enterprise Holdings Limited Overview
RENHENG is a micro-cap, single-segment, China-only manufacturer of special-purpose tobacco primary-processing machinery, operating through its wholly owned Jiangsu subsidiary Baoying Renheng. It holds a Tobacco Monopoly Production Enterprise Licence issued by the State Tobacco Monopoly Administration and describes itself as one of 35 licensed manufacturers in the PRC — a regulatory moat that restricts entry into a market whose end customers are the cigarette factories and leaf redrying plants of the state tobacco monopoly. Revenue is dominated by project-based, customised "casing and flavouring systems" (80–95% of sales in recent periods), supplemented by pneumatic feeding systems and occasional pre-pressing packing machines. The business is lumpy, tender-driven and highly customer-concentrated (top five customers 75.7% of FY2025 sales). It carries no debt and a net cash position of roughly HK$105–123M against a market value of about HK$160M, but faces sharp bid-price compression in 2026 and a long-stated, still-unrealised ambition to diversify into non-tobacco automation.
What the company does
RENHENG's listed holding company is an investment holding vehicle that also provides corporate management services; substantially all operations sit in Baoying Renheng, located in Baoying County, Jiangsu Province (AR2025, Report of Directors and ESG Report). The Group manufactures, sells, and provides maintenance, overhaul and modification services for tobacco machinery products in the PRC. Its licence from the State Tobacco Monopoly Administration permits it to manufacture, sell and service catalogued special-purpose tobacco machinery (AR2025 MD&A).
The company's own description (paraphrased from AR2025 and IR 1H2026)
Management describes the Group as generating turnover mainly from projects involving catalogued special-purpose tobacco machinery — chiefly the casing and flavouring system and the pneumatic feeding system, with the 1H2026 interim report also listing the pre-pressing packing machine as a third principal product type. Management characterises its principal customer as the "Tobacco Monopoly Administration of the PRC" (in practice, the provincial China Tobacco industrial companies and their cigarette factories and redrying plants), asserts that the domestic tobacco machinery industry should see steady momentum because cigarette makers continually replace machines with more technologically advanced equipment, and states an intention to use its customisation and development capabilities to win non-standard automated machinery contracts in other industries.
Business model and revenue model
| Dimension | Characterisation | Evidence |
|---|---|---|
| Revenue type | Predominantly project/product revenue; no subscription or licensing revenue disclosed | RA2025 Note 4 |
| Product vs. service mix | Product/project revenue ~100% of reported revenue; maintenance/overhaul/modification services are part of the licensed scope but not separately reported | RA2025 Note 4 |
| Revenue recognition | Point in time for all streams. Casing and flavouring systems recognised when the completed system transfers to the customer (no enforceable right to payment before transfer); other products on delivery | RA2025 Note 4(ii) |
| Customer prepayments | 10%–30% of contract value received as deposit on signing, creating contract liabilities throughout construction | RA2025 Note 4(ii), Note 13 |
| Credit terms | Normally 90 days upon delivery / three months | RA2025 Note 4(ii), Note 11 |
| Warranty | Defect liability period of one to three years (FY2025 AR/RA); one to two years stated in IR 1H2026 | RA2025; IR 1H2026 |
| Contract pricing | Fixed-price, customer-specified, non-standard customised equipment; won through bidding | RA2025; IR 1H2026 |
| Procurement | Project-specific procurement after contract signing, from an approved-supplier list reviewed annually; 946 suppliers in FY2025, 807 in Eastern China | AR2025 ESG Report B5 |
Value-chain position
RENHENG sits in the equipment tier of the Chinese tobacco value chain, supplying the "primary processing" (制丝) stage of cigarette manufacturing — the cut-tobacco preparation process in which leaf is conditioned, cased (moistened with casing liquid), cut, dried, flavoured and conveyed to cigarette-making machines. Pre-pressing packing machines serve leaf redrying factories upstream. It does not make cigarette-making or packing machines (the "secondary processing" stage). Its customers are state-owned enterprises within the China National Tobacco monopoly system; it also received "Excellent Supplier" recognition in 2022 and 2023 from Qinhuangdao Tobacco Machinery Co., Ltd., a company controlled by China Tobacco Machinery Group (RA2023 MD&A), indicating that it also supplies or subcontracts to the state-owned tobacco machinery group itself.
Customer types and end-markets
| Customer type | Products sold | Source |
|---|---|---|
| Cigarette manufacturers (provincial China Tobacco industrial companies' factories) | Casing and flavouring systems; pneumatic feeding systems; other goods | RA2025 Note 4(ii) |
| Tobacco leaf redrying factories | Pneumatic feeding systems; pre-pressing packing machines; other goods | RA2025 Note 4(ii) |
| Tobacco machinery group companies (e.g., Qinhuangdao Tobacco Machinery) | Not specified; supplier award disclosed | RA2023 MD&A |
End-market: 100% PRC tobacco industry in every year FY2021–FY2025 and 1H2026 (RA2025 Note 4; IR 1H2026 Note 4). The ESG report also references inspection specifications for water treatment equipment products, consistent with small historical water-treatment sales (AR2025 ESG B6; RA2023).
Independent characterisation
RENHENG is best understood as a licensed niche contractor to a single state monopoly. Its economics are governed by three variables: (i) the number and size of factory upgrade projects tendered by China Tobacco's provincial companies; (ii) bid pricing, which in 1H2026 collapsed as competition among bidders intensified and client budgets were cut (IR 1H2026); and (iii) the timing of customer acceptance, because revenue is recognised only on completion and transfer. The licence restricts new entry but does not protect price. The Group's real competitive assets are its licence, its installed base and relationships, and a debt-free balance sheet; its weaknesses are scale (138 employees), extreme concentration, and an unrealised diversification agenda that has appeared in substantially similar wording in every annual report since at least FY2023.
Strategy
Stated strategy (themes from AR2025, RA2025 and IR 1H2026, paraphrased)
-
Defend the licensed tobacco machinery franchise. Management repeatedly frames its status as one of 35 licensed manufacturers and a supplier to the tobacco monopoly as a stable financial foundation, relying on cigarette factories' continued replacement of machinery with more technologically advanced equipment.
-
Diversify the revenue structure. Both within tobacco (additional product types) and outside it, by offering non-standardised automatic machinery to other industries that need customised automation, leveraging product customisation, development capability and brand.
-
Innovate in key technologies for customised automated machinery. R&D spending rose 45.4% in FY2025, attributed to strengthening product functions and establishing new product lines in other industries (RA2025).
-
Internal management and digitalisation (new in IR 1H2026). Strengthening internal controls and deploying internal digital management systems — including paperless design software and an upgraded integrated project-management platform — to stabilise existing operations and accelerate new business in "new-technological fields".
-
Conservative capital structure. Maintaining no borrowings and a large cash buffer as insulation against volatility (RA2022 MD&A theme, maintained since).
Initiatives in the last 24 months
| Initiative | Date disclosed | Status / quantification | Source |
|---|---|---|---|
| R&D increase towards new product lines in other industries | 30 Mar 2026 | FY2025 R&D HK$6.696M (+45.4%); no named non-tobacco product or revenue disclosed | RA2025 |
| Increased business promotion, advertising and tender consultancy | 30 Mar 2026 | FY2025 selling expenses +HK$3.8M to HK$10.2M | RA2025 |
| Digital management systems (paperless design software, integrated project-management platform upgrade) | 27 Aug 2026 | No budget disclosed | IR 1H2026 |
| Climate-related resource-efficiency programme | 28 Apr 2026 | Management expects continued technological innovation and digitalisation to save 1%–2% of total operating costs annually over the next three years | AR2025 ESG Part D |
| Energy-efficient/eco-friendly products | 28 Apr 2026 | Management expects revenue share of related new products to rise from below 5% to 10%–15% within three years | AR2025 ESG Part D |
| Governance modernisation (new articles for hybrid meetings and electronic communications) | Mar 2026 (proposal); approved at 25 Jun 2026 AGM per vendor summaries | Administrative | TipRanks summaries of HKEX announcements |
| Board refresh (Big Four audit partner as INED) | 31 Oct 2025 | Completed | HKEX announcement |
Medium-term targets and guidance
The Company does not publish revenue, margin or earnings guidance, investor-day targets or capital-return targets. The only forward-looking quantified statements are the climate-section expectations above (1%–2% annual operating-cost savings; 10%–15% revenue share from energy-efficient products within three years), which are indicative rather than formal guidance. The profit warning of 19 August 2026 is the most recent formal forward-looking disclosure, and it related only to the completed half-year.
Products & Services
All products sit within the single tobacco machinery segment. Pricing is contract-specific and determined through bids; list prices are not publicly disclosed. Launch years and detailed technical specifications are not disclosed in the annual reports; descriptions below are based on filings and standard functional definitions of the equipment category.
Casing and flavouring system (加料加香系統) — flagship
| Attribute | Detail |
|---|---|
| Description | Customised process systems used in the cut-tobacco primary processing line to apply casing liquids and flavourings to tobacco leaf/strips and cut filler under controlled ratios, moisture and temperature |
| Commercial form | Construction contracts; fixed price; customer-specified design with no alternative use; delivered, installed and accepted on site |
| Target customer | Cigarette factories of provincial China Tobacco industrial companies |
| Revenue FY2025 | HK$86.375M (80.4% of revenue); 1H2026 HK$96.306M (95.4%) |
| Gross margin | 32.9%–47.8% annually FY2021–FY2025; collapsed to 24.8% in 1H2026 from 45.8% in 1H2025 |
| Contract economics | 10%–30% deposit; 1–3 year defect liability; retention money receivables held by customers (HK$8.4M gross at end-2025) |
| Order visibility proxy | Contract liabilities for casing and flavouring systems: HK$70.5M (end-2021), HK$68.3M (end-2022), HK$45.1M (end-2023), HK$47.5M (end-2024), HK$95.5M (end-2025) |
| Launch / latest version | — |
| Sources | RA2022–RA2025 Notes 4 and 13; IR 1H2026 |
Pneumatic feeding system (風力送絲系統)
| Attribute | Detail |
|---|---|
| Description | Air-conveying systems that transport cut tobacco from storage/blending to cigarette-making machines; the AR2025 climate disclosure refers to a "Pneumatic Silk Conveying System" |
| Commercial form | Product sale recognised on delivery; 90-day credit |
| Target customer | Cigarette manufacturers and redrying factories |
| Revenue | FY2021 HK$14.5M; FY2022 HK$9.9M; FY2023 HK$18.8M; FY2024 HK$3.5M; FY2025 HK$18.4M; 1H2026 HK$3.8M |
| Gross margin | Consistently the highest-margin line (approx. 46%–56% annually) |
| Strategic note | Management attributes part of FY2025's profit rise to this line's mix increase to 17.1% |
| Launch / latest version | — |
Pre-pressing packing machine (預壓打包機)
| Attribute | Detail |
|---|---|
| Description | Machinery used at leaf redrying plants to pre-press and pack redried tobacco into cases/bales |
| Revenue | FY2021 HK$15.4M (20.9% of sales); nil FY2022–FY2024; FY2025 HK$2.0M |
| Gross margin | FY2025 approx. 19.4% (HK$0.396M gross profit) |
| Status | Re-listed by management as one of three principal products in IR 1H2026 |
Water treatment systems
| Attribute | Detail |
|---|---|
| Description | Small water treatment equipment sales; the Group maintains an inspection specification for water treatment equipment manufacturing |
| Revenue | FY2021 HK$0.69M; FY2022 HK$0.71M; FY2023 HK$0.27M; not separately reported FY2024–FY2025 |
| Sources | RA2022; RA2023; AR2025 ESG B6 |
Other goods
Spare parts, components and miscellaneous goods: HK$5.8M (FY2021), HK$2.9M (FY2022), HK$2.5M (FY2023), HK$2.7M (FY2024), HK$0.6M (FY2025), HK$0.9M (1H2026). Separately, sales of scrap materials, parts and components are booked in other gains (HK$1.267M in FY2025).
Additional equipment referenced by data vendors
Third-party profiles (Simply Wall St, TipRanks) list dedusting systems and swelling-agent delivery systems among the Group's offerings. These are not separately reported in the filings reviewed and are presumably included in "other goods" or within system contracts.
Services
Maintenance, overhaul and modification services for tobacco machinery are within the licensed scope (AR2025 MD&A) but are not reported as a separate revenue stream.
Financial Narrative
All figures HK$ millions unless stated. Sources: RA2022 (FY2021–FY2022), RA2023 (FY2023), RA2025 (FY2024–FY2025).
Income statement
No dilutive instruments existed in any year; diluted EPS equals basic. EBITDA is therefore marked "not publicly disclosed" for formal purposes.
Margin analysis
Revenue CAGR FY2021–FY2025 (four compounding years): approx. 9.9% (analyst-computed: 107.422 / 73.731 = 1.457x). The FY2022 effective tax rate is not meaningful (tax charge on a pre-tax loss, driven by PRC withholding tax and deferred tax).
Commentary. The five-year record shows a fixed-cost structure (selling plus administrative plus R&D of roughly HK$29–38M) that only becomes profitable when revenue exceeds roughly HK$90–100M at historical gross margins. FY2021–FY2022 revenue of ~HK$70M produced operating losses; FY2023's 80% revenue jump produced operating leverage to an 11.7% operating margin. FY2025 is the anomaly: revenue fell 6.5% but gross margin jumped 14.4 points to 47.9%, which management attributes to project-pricing variations from quotation strategies and bid types on non-standard equipment, plus the mix shift towards pneumatic feeding systems (RA2025 MD&A). A HK$2.8M reversal of inventory allowance (versus a HK$1.1M charge in FY2024) also flattered FY2025 cost of sales. The 1H2026 interim then reversed the margin gain: gross margin fell to 26.3% on what management describes as a significant drop in contracted selling prices due to bidder competition and lower client budgets (IR 1H2026). Investors should therefore treat FY2025 margins as a peak rather than a new baseline.
Tax: Baoying Renheng is taxed at 15% as an HNTE; additional PRC withholding tax on undistributed profits (HK$1.199M in FY2025) raises the effective rate. Hong Kong has no assessable profit.
Balance sheet
Notes: Accrued warranty provision was included within trade and other payables in FY2021–FY2023 (HK$3.289M, HK$3.273M, HK$5.406M respectively; RA2022, RA2023). Net debt is negative in every year (net cash). The FY2025 MD&A figure of HK$96.273M for "fixed deposits, FVTPL and cash" excludes pledged deposits.
Commentary. The balance sheet is liquidity-rich and debt-free, but a large part of current assets is contract work-in-progress funded by customer deposits. At end-2025, inventories of HK$105.4M (of which work-in-progress HK$102.7M; IR 1H2026 Note 11) were roughly matched by contract liabilities of HK$100.2M — the classic profile of a project contractor carrying a heavy backlog of uncompleted jobs. Receivables quality deteriorated in FY2024–FY2025: trade receivables past due more than 90 days rose to HK$22.0M at end-2025 (HK$27.2M at end-2024) from HK$1.5M at end-2023 (RA2023; RA2025), coinciding with a change in the ageing basis from invoice date to completion date. At 30 June 2026, only HK$1.7M of net trade receivables of HK$53.4M were aged 0–90 days (IR 1H2026), which merits monitoring despite the state-owned credit quality of the customers. Retained earnings have been negative (accumulated losses of HK$10.7M at end-2021 and HK$13.3M at end-2022; RA2022), and the Company reported no reserves available for distribution at end-2025 (AR2025), a technical constraint on dividends at the holding-company level.
Cash flow
FY2025 operating cash flow, capital expenditure and free cash flow: not publicly disclosed in sources retrieved. Indirect evidence: gross liquid funds (cash, fixed and pledged deposits, FVTPL) rose by HK$7.1M in FY2025 (HK$116.5M to HK$123.5M), including the effect of RMB appreciation on translation, with no dividends, buybacks or debt movements. Capital expenditure is evidently minimal: PPE declined from HK$23.0M (end-2022) to HK$17.8M (end-2025), implying additions below depreciation. No buybacks occurred FY2021–FY2025 or in 1H2026 (AR2025; IR 1H2026). No dividends were paid FY2016 onward per filings reviewed for FY2019–FY2025.
Ratio analysis (analyst-computed from filed figures)
ROIC uses NOPAT (operating income ex other income multiplied by one minus the effective tax rate; statutory 15% applied in loss years) over year-end equity less net cash; because net cash consumes most of equity, invested capital is small (HK$11–26M in FY2023–FY2025) and ROIC is consequently very high and volatile — it is a measure of the operating business's capital-lightness rather than of shareholder returns. Net debt/EBITDA and interest coverage are not meaningful (no debt, no finance costs). The very long cash conversion cycle reflects project WIP held in inventory; it is largely funded by customer deposits (contract liabilities), which the standard CCC formula ignores.
Trend commentary. Returns on equity are depressed by the cash pile: the operating business earns high returns on the small capital it actually uses, but ~85% of equity is cash and deposits yielding 0%–2.9% (IR 1H2026 Note 13). The inflection points are FY2023 (volume-driven recovery), FY2025 (margin-driven peak) and 1H2026 (volume up, margin down).
Interim snapshot (1H2026 vs 1H2025)
Source: IR 1H2026. Trailing-twelve-month revenue to 30 June 2026 is HK$147.8M and TTM net profit HK$8.6M (analyst-computed: 2H2025 plus 1H2026).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Role | Source |
|---|---|---|
RENHENG Enterprise Holdings Limited (Cayman) | Listed holding company; investment holding and corporate management services | AR2025 |
RENHENG Global Limited | Intermediate holding company (named in equity reserve note) | Interim Report 2025 |
Bao Ying Ren Heng Industrial Co., Ltd (寶應仁恒實業有限公司) | Wholly owned PRC operating subsidiary; licensed tobacco machinery manufacturer; HNTE | AR2025 ESG; IR 1H2026 |
LinkBest Capital Group Ltd / Open Venture Global Ltd | Controlling shareholders (wholly owned by Ms. Liu Li) | AR2025 |
Product Lines
| Product line | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Casing and flavouring systems (HKD Mn) | 37.316 | 55.551 | 102.897 | 108.722 | 86.375 |
Pneumatic feeding systems (HKD Mn) | 14.544 | 9.932 | 18.803 | 3.509 | 18.381 |
Pre-pressing packing machines (HKD Mn) | 15.398 | 0 | 0 | 0 | 2.040 |
Water treatment systems (HKD Mn) | 0.692 | 0.709 | 0.271 | 0 | 0 |
Other goods (HKD Mn) | 5.781 | 2.891 | 2.452 | 2.665 | 0.626 |
Total revenue (HKD Mn) | 73.731 | 69.083 | 124.423 | 114.896 | 107.422 |
Product Lines — Casing and flavouring systems
| Product line | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Casing and flavouring systems (% of revenue) | 50.6 | 80.4 | 82.7 | 94.6 | 80.4 |
Pneumatic feeding systems (% of revenue) | 19.7 | 14.4 | 15.1 | 3.1 | 17.1 |
Pre-pressing packing machines (% of revenue) | 20.9 | 0 | 0 | 0 | 1.9 |
Water treatment and other goods (% of revenue) | 8.8 | 5.2 | 2.2 | 2.3 | 0.6 |
Product Lines — Casing and flavouring gross profit
| Product line | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Casing and flavouring gross profit (HKD Mn) | 15.380 | 18.313 | 35.283 | 35.728 | 41.320 |
Casing and flavouring gross margin (%) | 41.2 | 33.0 | 34.3 | 32.9 | 47.8 |
Pneumatic feeding gross profit (HKD Mn) | 6.710 | 5.531 | 9.193 | 1.971 | 9.148 |
Pneumatic feeding gross margin (%, analyst-computed) | 46.1 | 55.7 | 48.9 | 56.2 | 49.8 |
Water treatment gross profit (HKD Mn) | 0.309 | 0.280 | 0.122 | 0 | 0 |
Group gross margin (%) | 38.4 | 37.0 | 36.7 | 33.5 | 47.9 |
Product Lines (FY2022–FY2025)
| Product line | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Casing and flavouring systems (YoY %) | 48.9 | 85.2 | 5.7 | -20.6 |
Pneumatic feeding systems (YoY %) | -31.7 | 89.3 | -81.3 | 423.8 |
Total revenue (YoY %) | -6.3 | 80.1 | -7.7 | -6.5 |
Results by Segment and Segment Margins & Growth (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Segment operating income (HKD Mn, analyst-computed) | -2.633 | -3.167 | 14.586 | 7.617 | 12.466 |
Segment operating margin (%) | -3.6 | -4.6 | 11.7 | 6.6 | 11.6 |
Segment pre-tax income (HKD Mn) | 3.368 | -0.588 | 17.918 | 10.334 | 16.925 |
Segment pre-tax margin (%) | 4.6 | -0.9 | 14.4 | 9.0 | 15.8 |
Revenue by Segment
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Average contract sum completed (HKD Mn) | 2.665 | 2.222 | 6.431 | 4.727 | 3.599 |
Revenue from three largest contracts (HKD Mn) | 32.441 | 33.134 | 77.348 | — | 48.894 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (Half-Yearly)
| Metric | H1 2024 | H2 2024 | H1 2025 | H2 2025 | H1 2026 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 60.979 | 53.917 | 60.640 | 46.782 | 100.977 |
Profit for the period (HKD Mn) | 7.555 | -0.520 | 13.058 | 0.897 | 7.685 |
Casing and flavouring revenue (HKD Mn) | — | — | 52.582 | 33.793 | 96.306 |
Pneumatic feeding revenue (HKD Mn) | — | — | 8.058 | 10.323 | 3.812 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 73.731 | 69.083 | 124.423 | 114.896 | 107.422 |
Cost of sales (HKD Mn) | 45.454 | 43.516 | 78.699 | 76.369 | 56.001 |
Gross profit (HKD Mn) | 28.277 | 25.567 | 45.724 | 38.527 | 51.421 |
Other income (HKD Mn) | 2.737 | 1.858 | 1.545 | 1.913 | 3.079 |
Other gains and losses net (HKD Mn) | 3.264 | 0.721 | 1.787 | 0.804 | 1.380 |
Credit loss charge (reversal) (HKD Mn) | 0.160 | -0.042 | -0.322 | 0.114 | 0.594 |
Selling and distribution expenses (HKD Mn) | 9.212 | 7.797 | 10.210 | 6.452 | 10.243 |
Administrative expenses (HKD Mn) | 17.030 | 16.655 | 16.578 | 19.739 | 21.422 |
R&D expenses (HKD Mn) | 4.508 | 4.324 | 4.672 | 4.605 | 6.696 |
Operating income ex other income (HKD Mn, analyst-computed) | -2.633 | -3.167 | 14.586 | 7.617 | 12.466 |
Finance costs (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Profit before tax (HKD Mn) | 3.368 | -0.588 | 17.918 | 10.334 | 16.925 |
Taxation (HKD Mn) | 2.647 | 1.775 | 4.360 | 3.299 | 2.970 |
Net profit attributable (HKD Mn) | 0.721 | -2.363 | 13.558 | 7.035 | 13.955 |
FX translation OCI (HKD Mn) | 3.021 | -9.514 | -1.493 | -2.410 | 2.856 |
Total comprehensive income (HKD Mn) | 3.742 | -11.877 | 12.065 | 4.625 | 16.811 |
Basic EPS (HK cents) | 0.09 | -0.29 | 1.69 | 0.88 | 1.74 |
Diluted EPS (HK cents) | 0.09 | -0.29 | 1.69 | 0.88 | 1.74 |
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 38.4 | 37.0 | 36.7 | 33.5 | 47.9 |
Operating margin ex other income (%) | -3.6 | -4.6 | 11.7 | 6.6 | 11.6 |
Pre-tax margin (%) | 4.6 | -0.9 | 14.4 | 9.0 | 15.8 |
Net margin (%) | 1.0 | -3.4 | 10.9 | 6.1 | 13.0 |
Effective tax rate (%) | 78.6 | -301.9 | 24.3 | 31.9 | 17.5 |
Selling expense ratio (%) | 12.5 | 11.3 | 8.2 | 5.6 | 9.5 |
Administrative expense ratio (%) | 23.1 | 24.1 | 13.3 | 17.2 | 19.9 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Property plant and equipment (HKD Mn) | 7.640 | 22.967 | 21.061 | 18.697 | 17.788 |
Investment properties (HKD Mn) | 21.893 | 0 | 0 | 0 | 0 |
Right-of-use assets (HKD Mn) | 2.680 | 5.115 | 5.021 | 4.620 | 4.702 |
Inventories (HKD Mn) | 76.282 | 97.097 | 72.554 | 56.296 | 105.373 |
Trade and other receivables (HKD Mn) | 41.452 | 30.987 | 38.780 | 49.380 | 46.611 |
Of which trade-related receivables net (HKD Mn) | 19.338 | 17.020 | 27.912 | 43.764 | 39.996 |
Financial assets at FVTPL (HKD Mn) | 0 | 0 | 0 | 21.598 | 0 |
Restricted or pledged bank deposits (HKD Mn) | 22.011 | 5.087 | 12.001 | 19.848 | 27.267 |
Fixed deposits (HKD Mn) | 0 | 0 | 0 | 15.500 | 17.322 |
Cash and cash equivalents (HKD Mn) | 96.040 | 97.195 | 86.100 | 59.532 | 78.951 |
Total assets (HKD Mn) | 267.998 | 258.448 | 235.517 | 245.471 | 298.014 |
Trade and other payables (HKD Mn) | 54.808 | 47.590 | 42.024 | 29.300 | 35.313 |
Warranty provision separately presented (HKD Mn) | 0 | 0 | 0 | 5.206 | 4.800 |
Contract liabilities (HKD Mn) | 80.100 | 90.153 | 57.828 | 71.847 | 100.225 |
Tax payable (HKD Mn) | 7.740 | 6.995 | 10.387 | 9.280 | 11.249 |
Lease liabilities (HKD Mn) | 0.300 | 0 | 0.212 | 0 | 0.205 |
Deferred tax liabilities (HKD Mn) | 1.852 | 2.389 | 1.680 | 1.827 | 1.400 |
Short-term debt (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Long-term debt (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Total equity (HKD Mn) | 123.198 | 111.321 | 123.386 | 128.011 | 144.822 |
Goodwill and intangibles (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Net current assets / working capital (HKD Mn) | 92.837 | 85.628 | 98.984 | 106.521 | 123.732 |
Gross liquid funds incl. pledged fixed and FVTPL (HKD Mn, analyst-computed) | 118.051 | 102.282 | 98.101 | 116.478 | 123.540 |
Net cash after leases (HKD Mn, analyst-computed) | 117.751 | 102.282 | 97.889 | 116.478 | 123.335 |
Net cash per share (HK$, analyst-computed) | 0.146 | 0.127 | 0.122 | 0.145 | 0.153 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
Operating cash flow (HKD Mn; aggregator) | 10.640 | -7.211 | -3.323 | 19.978 |
Dividends paid (HKD Mn) | 0 | 0 | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE on average equity (%) | 0.6 | -2.0 | 11.6 | 5.6 | 10.2 |
ROA on average total assets (%) | 0.3 | -0.9 | 5.5 | 2.9 | 5.1 |
ROIC on year-end equity less net cash (%) | -9.0 | -35.0 | 43.3 | 45.1 | 47.8 |
Current ratio (x) | 1.65 | 1.59 | 1.90 | 1.92 | 1.82 |
Quick ratio as reported by company (x) | 1.1 | 0.9 | 1.2 | 1.4 | 1.1 |
Debt to equity (x) | 0 | 0 | 0 | 0 | 0 |
Asset turnover on average assets (x) | 0.28 | 0.26 | 0.50 | 0.48 | 0.40 |
Days inventory on average balance (days) | 613 | 727 | 393 | 308 | 527 |
Days sales outstanding, trade-related, average (days) | 96 | 96 | 66 | 114 | 142 |
Days payables, trade and bills, average (days) | 351 | 336 | 144 | 110 | 143 |
Cash conversion cycle (days) | 358 | 487 | 315 | 312 | 526 |
Balance Sheet and Margin Analysis (%)
| Metric | H1 2025 | H1 2026 |
|---|---|---|
Revenue (HKD Mn) | 60.640 | 100.977 |
Gross profit (HKD Mn) | 27.573 | 26.516 |
Gross margin (%) | 45.5 | 26.3 |
Selling and distribution costs (HKD Mn) | 2.382 | 4.339 |
Administrative expenses (HKD Mn) | 9.882 | 11.534 |
R&D costs (HKD Mn) | 2.033 | 2.186 |
Profit before tax (HKD Mn) | 15.585 | 9.590 |
Profit for the period (HKD Mn) | 13.058 | 7.685 |
Basic EPS (HK cents) | 1.62 | 0.96 |
Total staff costs (HKD Mn) | 10.658 | 12.206 |
Inventories at period end (HKD Mn) | — | 64.776 |
Contract liabilities at period end (HKD Mn) | — | 56.752 |
Total equity at period end (HKD Mn) | — | 157.276 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Region and Revenue by Region (%)
| Region | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
PRC revenue (HKD Mn) | 73.731 | 69.083 | 124.423 | 114.896 | 107.422 |
Outside PRC revenue (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
PRC share of revenue (%) | 100 | 100 | 100 | 100 | 100 |
PRC revenue growth (YoY %) | -3.3 | -6.3 | 80.1 | -7.7 | -6.5 |
Supplier Region Details
| Supplier region | Number of suppliers FY2025 |
|---|---|
Eastern China | 807 |
Central China | 48 |
Western China | 45 |
North-eastern China | 11 |
Others | 35 |
Total | 946 |
Valuation Snapshot
| Metric | Value | Basis / source |
|---|---|---|
Share price | approx. HK$0.20 | TipRanks quote page (accessed 12 Oct 2026) |
52-week range | HK$0.17 – HK$0.31 | TipRanks |
Shares in issue | 804,000,000 | IR 1H2026 |
Market capitalisation | approx. HK$161.6M (approx. US$20.7M) | TipRanks; USD at approx. 7.8 HKD peg |
Net cash at 30 Jun 2026 (cash, fixed and pledged deposits less leases) | HK$104.9M | IR 1H2026, analyst-computed |
Enterprise value | approx. HK$56.6M | Analyst-computed |
P/E on FY2025 EPS | approx. 11.5x | HK$0.20 / HK$0.0174 |
P/E on TTM to Jun 2026 | approx. 18.8x | TTM profit HK$8.6M |
EV / TTM sales | approx. 0.38x | TTM revenue HK$147.8M |
EV / FY2025 operating income (ex other income) | approx. 4.5x | Proxy for EV/EBITDA (EBITDA not disclosed) |
P/B at 30 Jun 2026 | approx. 1.03x | Equity HK$157.3M |
Average daily volume (3 months) | approx. 202,000 shares (approx. HK$40,000) | TipRanks |
Share Price & Returns
| Horizon | Performance | Source |
|---|---|---|
1 year | Approximately flat (market cap approx. HK$164.8M in late Aug 2025 versus approx. HK$161.6M now) | TipRanks article Aug 2025; TipRanks quote |
Since GEM IPO (Nov 2011, HK$1.20 pre-subdivision = HK$0.30 adjusted) | Approx. −33% (excluding dividends) | GEM allotment announcement; ROIC.ai split data |
Capital Markets
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Dividend per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Dividends paid (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Capital Markets — Buyback authorisation used
| Item | Status | Source |
|---|---|---|
Buyback authorisation used | No repurchases FY2021–1H2026 | AR2025; IR 1H2026 |
General issuance mandate | Sought at 2026 AGM | TipRanks summary |
Moody's / S&P / Fitch ratings | Not rated | — |
Debt maturity profile | No borrowings; lease liability HK$0.115M at 30 Jun 2026 | IR 1H2026 |
Bills payable (trade finance, secured by pledged deposits) | HK$4.4M at 30 Jun 2026 | IR 1H2026 Note 14 |
Analyst Conclusions
Management guidance
No numerical guidance. Management's qualitative outlook (IR 1H2026) is that the tobacco machinery industry will remain steady, that the monopoly customer provides a stable financial foundation, and that the Group will strengthen internal management, digitalise design and project management, and pursue contracts in more than one machinery industry or new technological fields. Consensus estimates: none (no analyst coverage).
Bull case
-
Volume is strong and the balance sheet is a floor. 1H2026 revenue of HK$101.0M was 94% of FY2025's full-year revenue; with net cash of approx. HK$105M (approx. HK$0.13 per share) against a HK$0.20 share price, the market ascribes only about HK$57M of enterprise value to an operating business that earned HK$12.5M of operating income in FY2025.
-
Margin compression may be partly cyclical. Casing GPM has ranged from 32.9% to 47.8% across FY2021–FY2025; 1H2026's 24.8% could reflect a cluster of aggressively priced bids rather than a permanent reset, and the higher-margin pneumatic line (approx. 50% GPM) could rebound from its depressed 1H2026 level.
-
Optionality on capital return or diversification. The cash pile, positive operating ROIC and growing R&D budget (HK$6.7M in FY2025) give the controlling shareholder levers to raise returns via distributions or to launch non-tobacco automation products.
Bear case
-
Structural price erosion. Management explicitly cites both competitor pricing and client budget cuts; if 1H2026 economics persist, a full-year operating margin in low single digits is plausible given the expense base of approx. HK$36–38M per year.
-
Backlog and collections are weakening. Contract liabilities nearly halved to HK$56.8M in 1H2026 and WIP fell to HK$61.8M, while net trade receivables rose to HK$53.4M with almost all aged over 90 days — signalling slower 2H2026 revenue and cash conversion.
-
Governance and liquidity discount is durable. A 74.6% controller who is also Chairman and CEO, no dividends for a decade per filings reviewed, average daily turnover of roughly HK$40,000, two executive-director departures in 20 months and recurring disclosure inconsistencies mean the cash may never be distributed to minorities.
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters | Timing |
|---|---|---|
| FY2026 annual results | Full-year margin outcome after 1H2026 compression; 2H2026 revenue given lower backlog | Board meeting expected around end-March 2027 (TipRanks shows 31 Mar 2027) |
| Casing and flavouring GPM trajectory | Tests whether 24.8% is a trough or a new norm | FY2026 results |
| Contract liabilities and WIP | Order visibility for FY2027 | FY2026 balance sheet |
| Trade receivable collections and ECL charges | Cash conversion and credit quality | FY2026 results |
| HNTE renewal | Tax rate 15% vs 25% | During 2026–2027 |
| First non-tobacco contract or product disclosure | Validation of diversification strategy | Any time |
| Capital-return decision (dividend/special distribution/buyback) | Unlocks discount to net cash | FY2026 results |
| Nomination committee composition (B.3.5 compliance) | Governance remediation | Promised further announcement |
| Further board changes | Stability of executive bench (board at five) | Ongoing |
| RMB/HK$ exchange rate | Translation of RMB-denominated equity and cash | Ongoing |
Analyst verdict
RENHENG is a small, licensed, debt-free supplier of customised primary-processing equipment to China's tobacco monopoly whose investment case rests almost entirely on the relationship between its cash and its controller. The operating business is real and capital-light: across FY2023–FY2025 it generated cumulative operating income of approx. HK$34.7M on minimal invested capital, and the regulatory licence protects it from new entrants. But the licence does not protect price, and the 1H2026 interim demonstrated how quickly margins can compress when provincial clients tighten budgets and the other licensed manufacturers bid aggressively — casing and flavouring gross margin fell by 21 percentage points year on year even as volumes surged.
FY2025's record 47.9% gross margin should therefore be regarded as a peak, not a run-rate. A normalised view — group gross margin in the mid-30s on revenue of HK$100–130M against an expense base approaching HK$38M — implies operating income in the high single-digit millions of HK dollars, and therefore an enterprise value multiple that looks undemanding at roughly five to seven times. The equity trades at about 1.0x book with roughly two-thirds of the market value backed by net cash.
The obstacle is governance and liquidity. Ms. Liu Li controls 74.6% and holds both the Chair and CEO roles; no dividend has been paid in the filings reviewed for FY2019–FY2025 despite consistent net cash above HK$95M; trading liquidity is negligible; disclosure contains avoidable inconsistencies; and the diversification strategy has been restated for years without visible revenue. Until the controller signals a willingness to share the cash — through a special dividend, buyback or privatisation offer — the discount is likely to persist.
Verdict: a statistically cheap, high-risk, illiquid special situation.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Age (AR2025) | Background | Source |
|---|---|---|---|---|---|
Ms. Liu Li | Chairman, CEO, Executive Director; controlling shareholder (74.6%) | ED since 2 Feb 2011; Chairman and CEO since 4 May 2016 | 55 | Director of Yanlord Industry Investment since Feb 2007; oversees Baoying Renheng since 2008; responsible for planning, strategy, treasury, HR and administration; bachelor's in sport management, Beijing Sport University (1992) | AR2025; Webb-site |
Ms. Lew Lai Kuen | Executive Director | 10 Jul 2024 | 62 | Marketing manager at Yanlord Paper Limited from Aug 2003; earlier marketing officer at Oceancrete Limited (1986–2003) and clerk at Far East Polyfoam (1982–1985); professional diploma in logistics management (2005) | AR2025 |
Dr. Lam Lee G. | INED; Chairman of Audit Committee; member of Remuneration and Nomination Committees | 30 Jun 2022 | 66 | Solicitor of the High Court of Hong Kong; extensive multi-board INED career across HK, Singapore, Malaysia, Australia and London listings; holds degrees including MBA (Ottawa) and PhD (HKU); numerous public and chamber appointments | AR2025 |
Mr. Lam Chi Wing | INED; Chairman of Remuneration Committee; member of Audit and Nomination Committees | 19 Jul 2023 | 46 | Corporate management, strategy consulting and investment banking; BBA (HKU), MSc (PolyU), MBA (CUHK), EMPA (Tsinghua); INED of China Wantian (1854), Alco (328), Carry Wealth (643) | AR2025 |
Mr. Cheung Kwong Tat | INED; Chairman of Nomination Committee; member of Audit and Remuneration Committees | 31 Oct 2025 | 58 | Former founding regional managing partner of Western China at Deloitte China; served on Deloitte China Governance Board for over six years; HKICPA member since 1996; INED of Wonderful Sky Financial (1260), Nanshan Aluminium International (2610), Million Hope Industries (1897), Golden Leaf International (8549) | AR2025 |
Executive Leadership Team
| Name | Role | Background | Source |
|---|---|---|---|
Mr. Liu Yang | Director and Vice General Manager, Baoying Renheng; heads sales and marketing | Over 25 years in sales; joined Baoying Renheng June 2004; brother of Ms. Liu Li; bachelor's in marketing, Changchun University of Science and Technology | AR2025 |
Mr. Chan Kit Yan | Group VP of Operations and Financial Controller; executive director and legal representative of Baoying Renheng | Joined 2022; oversees sales, technical, production, HR, purchasing and administration at Baoying Renheng; University of Birmingham; CPA Australia associate | AR2025 |
Mr. Tsang Chi Hon | Company Secretary (since May 2022) | HKICPA member; previously CFO of Zuoan Fashion (NYSE-listed); company secretary and financial controller of Micron (International) Group | AR2025 |
Governance Overview
| Attribute | Status (AR2025; IR 1H2026) |
|---|---|
Board size | 5 (2 executive, 3 INEDs) following Mr. Wen Yuan's resignation on 20 Feb 2026 |
Independence | 60% INEDs |
Chair/CEO separation | Not separated — Ms. Liu Li holds both roles; disclosed deviation from CG Code C.2.1 every year |
Committees | Audit, Remuneration, Nomination — each composed entirely of INEDs; no separate corporate governance committee (the Board performs that function) |
Gender | Two female directors (both executive). The nomination committee has no female member; the Company disclosed non-compliance with CG Code B.3.5 in IR 1H2026 and says it is seeking a candidate |
Meetings FY2025 | Four board meetings attended by all serving directors; three audit committee meetings |
Family relationships | Mr. Liu Yang (senior management) is Ms. Liu Li's brother; AR2025 nonetheless states that directors have no relationships with each other, which is accurate at board level |
Connected transactions | None disclosed for FY2025 |
Competing interests | None disclosed |
Board & Management Changes
| Date | Change | Context | Source |
|---|---|---|---|
19 Jul 2023 | Mr. Kong Hing Ki (INED since 2011) resigns; Mr. Lam Chi Wing appointed | Refresh of long-tenured INED | RA2023 |
10 Jul 2024 | Mr. Xu Jiagui resigns as ED (other business commitments); Ms. Lew Lai Kuen appointed | Loss of the director with the longest operating tenure at Baoying Renheng (since 2002) | TipRanks summary; Webb-site |
6 Dec 2024 | Mr. Wen Yuan appointed ED | Background in pharmaceutical-sector management (Sinopharm, China Pharmaceutical Culture Society) | HKEX announcement 6 Dec 2024 |
31 Oct 2025 | Mr. Wu Wei resigns as INED; Mr. Cheung Kwong Tat appointed | Adds Big Four audit-leadership experience | HKEX announcement 31 Oct 2025 |
20 Feb 2026 | Mr. Wen Yuan resigns as ED after approx. 14 months | — | AR2025 |
Major Shareholders
| Holder | Shares | % of issued | Nature | Source |
|---|---|---|---|---|
LinkBest Capital Group Limited (100% Ms. Liu Li) | 360,000,000 | 44.8 | Beneficial owner | IR 1H2026 |
Open Venture Global Limited (100% Ms. Liu Li) | 240,000,000 | 29.9 | Beneficial owner | IR 1H2026 |
Ms. Liu Li (aggregate, via controlled corporations) | 600,000,000 | 74.6 | Insider | IR 1H2026 |
Public float | 204,000,000 | 25.4 | Analyst-computed residual | — |
Competitive Landscape
Key Competitors
| # | Competitor | Ownership / listing | Overlap with RENHENG | Revenue | Relative positioning |
|---|---|---|---|---|---|
| 1 | China Tobacco Machinery Group (中國煙草機械集團) and subsidiaries | State-owned, unlisted | Full range of primary and secondary processing equipment | — | System integrator and dominant state supplier; also a RENHENG customer/award-giver |
| 2 | Qinhuangdao Tobacco Machinery Co., Ltd. | Controlled by China Tobacco Machinery Group | Primary processing lines | — | Larger line integrator; simultaneously customer (supplier award) and competitor |
| 3 | Shanghai Tobacco Machinery Co., Ltd. | State tobacco system, unlisted | Primary processing and cigarette-making machinery | — | Major state-system supplier |
| 4 | Changde Tobacco Machinery Co., Ltd. | State tobacco system, unlisted | Cigarette making and processing equipment | — | Major state-system supplier |
| 5 | Xuchang Tobacco Machinery Co., Ltd. | State tobacco system, unlisted | Cigarette making and processing equipment | — | Major state-system supplier |
| 6 | KSEC Intelligent Technology (Kunming Shipbuilding Equipment) | State-owned, unlisted | Primary processing lines, logistics automation | — | Large primary-processing line integrator |
| 7 | Other licensed private manufacturers (approx. 30 of the 35 licensees) | Mostly private, unlisted | Specialised sub-systems (casing, flavouring, conveying, dedusting) | — | Direct bid competitors on sub-system tenders; source of 2026 price competition |
| 8 | Hauni Maschinenbau (Körber Group, Germany) | Private (Körber) | Primary processing and cigarette-making technology | Segment revenue not publicly disclosed | Global technology leader; limited direct presence via licensing and JVs |
| 9 | G.D S.p.A. (Coesia Group, Italy) | Private (Coesia) | Primarily secondary processing (making and packing) | Segment revenue not publicly disclosed | Indirect competitor |
| 10 | Garbuio Dickinson (Italy) | Private | Primary processing, redrying and leaf-threshing equipment | — | Competes in redrying/primary processing internationally |
| 11 | Comas S.p.A. (Italy) | Private | Primary processing and flavouring systems | — | Overlaps in casing and flavouring technology internationally |
“—” = not publicly disclosed.
Competitor Detail
| Metric (FY2025) | RENHENG |
|---|---|
Revenue | HK$107.4M |
Revenue growth | -6.5% |
Gross margin | 47.9% |
Operating margin (ex other income) | 11.6% |
R&D intensity | 6.2% |
Recent Developments
No contract-win announcements, litigation, regulatory sanctions, layoffs or guidance revisions (other than the profit warning) were identified.



